insights_auto
Why is GALT down 2.87%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.05
arrow_downward
-2.87%(-0.090) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
0.00
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
The Motley Fool
·
29 minutes ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Benzinga
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
BigGo Finance
·
18 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com